# Efficacy of a Low-Molecular-Weight Heparin (Bemiparin) in the Treatment of Chronic Foot Ulcers in Diabetic Patients

> **NCT00399425** · PHASE2,PHASE3 · TERMINATED · sponsor: **Spanish National Health System** · enrollment: 84 (—)

## Conditions studied

- Foot Ulcer, Diabetic
- Diabetic Angiopathies

## Interventions

- **DRUG:** bemiparin (low molecular weight heparin)

## Key facts

- **NCT ID:** NCT00399425
- **Lead sponsor:** Spanish National Health System
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2001-06
- **Primary completion:** —
- **Final completion:** 2004-04
- **Target enrollment:** 84 (—)
- **Last updated:** 2006-11-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00399425

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00399425, "Efficacy of a Low-Molecular-Weight Heparin (Bemiparin) in the Treatment of Chronic Foot Ulcers in Diabetic Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00399425. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*